Abstracts tagged "physical therapy and rehabilitation"

Abstract Number: 2173 • 2019 ACR/ARP Annual Meeting
Descriptive Analysis of Patient-Reported Home Exercise and Physical Activity and Their Associations with Patient Baseline Characteristics Following Total Knee Replacement
Carol Oatis¹, Nikko Mendoza ², William Murray ³, Bailey Novak ⁴, Wenjun Li ⁵, Hua Zheng ⁶ and Patricia Franklin ⁷, ¹Arcadia University, Philadelphia, PA, ²Fox Rehabilitation, Cherry Hill, NJ, ³Physical Therapy and Wellness Institute, Hatfield, PA, ⁴ATI Physical Therapy, Warrington, PA, ⁵Department of Medicine, University of Massachusetts Medical School, Worcester, MA, ⁶Department of Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, ⁷Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL
Background/Purpose: Total knee replacement (TKR) is one of the most common elective surgeries and is effective for managing knee pain in osteoarthritis. However functional outcomes…
Abstract Number: 1953 • 2018 ACR/ARHP Annual Meeting
Randomized Trial on Exercise at Late-Stage after Total Knee Replacement
Sara R. Piva¹, Michael Schneider¹, Charity Moore-Patterson¹, M. Beatriz Catelani¹, Alexandra Gil¹, Brian Klatt², Anthony DiGioia³, Gustavo J. Almeida¹, Samannaaz S. Khoja⁴, Gwendolin Sowa⁵ and James Irrgang¹, ¹Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ²Orthopaedic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, ³University of Pittsburgh Medical Center, Pittsburgh, PA, ⁴Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ⁵Physical Medicine and Rehabilitation, University of Pittsburgh Medical Center, Pittsburgh, PA
Background/Purpose: Total knee replacement (TKR) improves pain and quality of life; however, the functional limitations that existed for years before surgery tend to persist after…
Abstract Number: 2456 • 2015 ACR/ARHP Annual Meeting
Anti SRP+Ve Myositis in Childhood. Presentation and Physiotherapy Treatment of This Rare Childhood Myositis
Susan Maillard and Clarissa Pilkington, Paediatric Rheumatology, Great Ormond Street Hospital NHS Foundation Trust for Children, London, United Kingdom
Background/Purpose: Previously it was understood that all Myositis in childhood was Juvenile Dermatomyositis. More recently Myositis specific antibodies have been discovered and these appear to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].